India’s CDMOs and CRDMOs are benefiting from the rise in global biopharma outsourcing. With advanced manufacturing capabilities, cost efficiency, and strict compliance with international standards, Indian firms are becoming preferred partners. This growth boosts innovation, expands global reach, and strengthens India’s position in the pharmaceutical outsourcing industry.